[1]
2019. Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer. Clinics. 73, Suppl. 1 (Feb. 2019), e479s. DOI:https://doi.org/10.6061/clinics/2018/e479s.